BeyondSpring Receives Nasdaq Delisting Notice After 30 Days Below $1.00
BYSI sits 33% above its 52-week low of $0.566 on light trading volume (0.1× avg).
Summary
BeyondSpring received a Nasdaq delisting notice on September 17, 2026, after its stock traded below $1.00 for 30 consecutive business days. The company has until March 16, 2027, to regain compliance.
Key Events · Legal and Risk Events · BYSI
-
Nasdaq Delisting Notice Received
On September 17, 2026, Nasdaq notified BeyondSpring that its ordinary shares failed the $1.00 minimum bid price requirement for 30 consecutive business days under Listing Rule 5550(a)(2).
-
180-Day Compliance Period
The company has until March 16, 2027, to regain compliance by closing at or above $1.00 per share for at least ten consecutive business days.
-
Possible Additional Grace Period
If compliance is not regained by March 16, 2027, the company may be eligible for an additional 180-day compliance period, subject to Nasdaq staff determination.
-
Compounding Distress
The delisting notice follows the company's August 2026 10-Q, which disclosed going concern doubt and the termination of its Eli Lilly collaboration.
Analysis · BYSI · Life Sciences
BeyondSpring has been formally notified by Nasdaq that its ordinary shares no longer meet the $1.00 minimum bid price requirement, having traded below that threshold for 30 consecutive business days. The company now has 180 calendar days — until March 16, 2027 — to regain compliance by closing at or above $1.00 for at least ten consecutive business days. This comes against a backdrop of already severe distress: the company's most recent 10-Q disclosed going concern doubt and the termination of its Eli Lilly collaboration. A delisting notice materially raises the risk that the company loses its Nasdaq listing entirely, which would further impair liquidity and access to capital at a time when the company is already fighting for survival.
How filings like this one have moved
In the 30 days to Sep 18, 2026, 40.1% of the 362 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BYSI was trading at $0.75 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $30.8M. The 52-week trading range was $0.57 to $2.44. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.